HSB-510

N/A

Report date: 2024/01/25 16:18:56
NME

Base Information

Drug NameHSB-510
Drug Alias NameHDAC6-Pi3K-delta dual inhibitors (Tharimmune/National Center for Advancing Translational Sciences)HSB-510
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 3 kinase delta inhibitorsHistone deacetylase 6 inhibitors
TargetsPhosphatidylinositol 3 kinase deltaHistone deacetylase 6
Therapy Area/IndicationsSolid tumoursLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTharimmune IncNational Center For Advancing Translational Sciences
China Registration ClassN/A

Develop Information

Active CompaniesIndian Institute of Technology
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A